Physician profile
Eric M Wilson
NPI 1174604342
$16,268.12
in general payments reported to CMS, 2019-2025
23 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $125 · 2021: $12K · 2022: $1,678 · 2023: $253 · 2024: $700 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,327 · Food and Beverage: $921 · Education: $23.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,326.70 |
| Food and Beverage | $920.99 |
| Education | $23.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,304.71 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $665.47 | 2022-2024 | Ligasure, Sonicision, Endo Stitch |
| Ethicon US, LLC | $458.21 | 2019-2025 | Ethicon, Enseal |
| Covidien LP | $94.61 | 2019 | |
| Ethicon INC. | $91.36 | 2025 | |
| Shire North American Group INC | $69.05 | 2019 | |
| Innocoll Pharmaceuticals Limited | $55.97 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Merck Sharp & Dohme LLC | $48.50 | 2020-2023 | Keytruda |
| Smith+Nephew, INC. | $44.40 | 2020-2022 | |
| Heron Therapeutics, INC. | $43.13 | 2024 | Zynrelef |
| Novo Nordisk INC | $40.59 | 2019 | |
| Asensus Surgical, INC. | $38.61 | 2019 | |
| Kerecis Limited | $35.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $34.49 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Medical Device Business Services, INC. | $27.84 | 2024 | Echelon Flex |
| Pacira Pharmaceuticals Incorporated | $26.12 | 2019 | |
| Atricure, INC. | $25.28 | 2019 | |
| Rti Surgical, INC | $24.86 | 2023 | |
| Bioptics, INC. | $19.09 | 2019 | |
| Csl Behring | $18.54 | 2019 | |
| Davol INC. | $18.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.